02 May Important Medicine Safety Information Section 36 Approval – Phenylephrine Hydrochloric Injectiontm
Posted at 06:25h
in
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Abbott Laboratories SA (Pty) Ltd, would like to inform you that Phenylephrine hydrochloric injectionTM has been up scheduled from Schedule 1 to Schedule 4 status. However, Abbott is experiencing unforeseen delays in the implementation of the artwork following the up-scheduling of this product.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
30/04/2024
File Type:
pdf
Category:
Communication To Health Care Professionals